microdosing glp-1 perimenopause in & Menopause ✨ Let's talk about microdosing GLP-1 during perimenopause & menopause ✨ If you've ever said: • “I'm eating the same but gaining weight” • “My cravings Is Micro-Dosing GLP-1s Safe To

A study in The New England Journal of Medicine found that 59 percent of patients with NASH (non-alcoholic steatohepatitis) who took a high dose of semaglutide for 72 weeks saw improvement without worsening of fibrosis (or scarring)

[43] analyzing a nationwide claims database, reported increased risks of new-onset depression, anxiety, and suicidal ideation among GLP-1 RA users, especially in women and younger individuals

8b1b3) 52

Many patients find it faster and more cost-effective to order baseline labs directly, particularly when they want results quickly and dont want to navigate referral processes or insurance prior authorization

No Fluff

Pharmaceutical Executive